Publication
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Journal Paper/Review - Aug 8, 2016
Jörger Markus, Behringer D M, Ko Y-D, Hilger R A, Roessler M, Kloft C, Henrich A, Moritz B, Miller M C, Salamone S J, Kopp H-G, Mayer F, von Pawel J, Kraff S, Fischer J R, Eberhardt W, Gauler T C, Mueller L, Reinmuth N, Reck M, Kimmich M, Jaehde U
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
189
48
von Pawel, J
1
0
Kraff, S
1
0
Fischer, J R
1
0
Eberhardt, W
1
0
Gauler, T C
1
0
Mueller, L
1
0
Reinmuth, N
1
0
Reck, M
4
0
Kimmich, M
2
0
Mayer, F
7
0
Kopp, H-G
1
0
Behringer, D M
1
0
Ko, Y-D
1
0
Hilger, R A
1
0
Roessler, M
1
0
Kloft, C
1
0
Henrich, A
1
0
Moritz, B
1
0
Miller, M C
1
0